FCA authorised · FRN 724952 0117 325 0027Quote & buy →
Aipedia: Aesthetics clinics
No regulator has issued AI-specific rules for aesthetics, so existing prescribing, consent, advertising and data protection rules govern every AI tool a clinic uses. That matters because aesthetics combines patchy regulation with treatment claims exposure and law reform in progress.
Part of: AI in aesthetics clinics
In short
UK aesthetics clinics may use AI for skin analysis, result simulations, marketing images, chatbots, online consultation forms, consent paperwork and device settings. No aesthetics-specific AI guidance exists. Instead, GMC cosmetic guidance, the NMC and GDC codes, CAP advertising rules and UK GDPR apply to the tools. Doctors, nurses and dentists must hold indemnity by law; non-healthcare injectors currently do not. DHSC is consulting until 13 January 2027 on restricting high-risk procedures, and a licensing scheme for toxins and fillers is planned. Malpractice cover usually expects a human practitioner to make the clinical decision.
AI has arrived in aesthetics through the consultation room, the marketing feed and the treatment device. Uses across clinics, salons and independent injectors can include:
Each use sits on top of a clinical or advertising duty that already exists. The AI does not change who is responsible.
There is no single aesthetics regulator. Who regulates the work depends on who performs it:
| Practitioner | Regulator | Indemnity required by law? |
|---|---|---|
| Doctors | GMC | Yes (Medical Act 1983 s44C) |
| Nurses and nurse prescribers | NMC | Yes |
| Dentists | GDC | Yes |
| Pharmacists | GPhC | Yes |
| Non-healthcare practitioners | None in England at present | No (JCCP) |
Alongside them, the ASA and CAP police advertising, the MHRA regulates medicines and devices, and the Joint Council for Cosmetic Practitioners runs a PSA-accredited register. Under the October 2026 proposals the CQC would enforce restrictions on high-risk procedures. None of these bodies has published AI guidance for aesthetics, but on 17 September 2026 the GMC, NMC, GDC, GPhC and other regulators signed a PSA-led joint statement of intent on AI principles that applies to their registrants.
The GMC cosmetic interventions guidance contains the duties most likely to be tested by an AI tool. Para 11 requires a physical examination before prescribing injectable cosmetic medicines and rules out prescribing online or at the request of others. Para 16 says the practitioner performing the procedure must seek consent personally. Paras 24 to 26 require time and information for a voluntary decision. Paras 47 to 49 require marketing to follow the CAP Codes, be factual and responsible, and not exploit vulnerability or trivialise risk.
For advertising, CAP rule 12.12 bans advertising prescription-only medicines to the public, and the CAP advice of 29 October 2025 says almost any public reference to Botox, including hashtags, is likely to be an implied POM ad. CAP rules 3.47 to 3.50 treat before-and-after photos like testimonials that must be genuine. The ASA ruling against Glow Up LLC on 2 September 2026 banned ads for an AI face-scoring app as misleading and irresponsible.
Consultation photos and skin analyses are special category health data. Since 5 February 2026, section 80 of the Data (Use and Access) Act 2025 sets safeguards for significant decisions based solely on automated processing, such as a tool that decides treatment suitability without meaningful human involvement. The full detail is in our guide to the rules that apply in 2026.
Section 180 of the Health and Care Act 2022 lets the Secretary of State license practitioners and premises in England, but no regulations have yet been made. On 21 October 2026 DHSC opened a consultation on high-risk cosmetic and wellbeing procedures, closing 13 January 2027. It proposes limiting certain high-risk treatments, including some laser procedures, to doctors, dentists, independent prescribing nurses, midwives and pharmacists, classing liquid BBL as surgery for doctors only, and banning specified treatments for under-18s, with breaches a criminal offence enforced by the CQC. A separate licensing scheme for toxins and fillers is committed to but undated. Scotland has committed to a Non-surgical Cosmetic Procedures Bill. See licensing, AI and insurance.
Healthcare professionals must hold indemnity for private cosmetic work, and NHS indemnity excludes private practice. Non-healthcare practitioners have no statutory requirement in England at present, although the JCCP insurance guide asks DHSC to standardise requirements, align indemnity with procedure risk and cover psychological harm.
No insurer or regulator has published an AI statement specific to aesthetics. One medical defence organisation has said it will help members only where a human remains the decision maker and AI use is within their expertise, and excludes autonomous systems, product liability, software defects and data breaches. Commercial aesthetic malpractice and treatment-risk policies vary, but usually respond to treatment by a named, qualified practitioner, subject to the policy terms. Advertising complaints and data breaches may fall outside them. See aesthetic clinic insurance, our aesthetic PI guides and treatment liability versus medical malpractice.
Registrants may also find the AI in doctors hub and the AI in nursing and allied health hub useful, along with prescriber cover for toxins and fillers.
Apex arranges indemnity for aesthetics clinics, prescribers and injectors. A broker reviews your cover and explains how your policy treats AI-assisted consultations, simulations and device settings.
No. DHSC, the JCCP, the ASA and CAP and the professional regulators have not published AI guidance for aesthetics. Existing duties apply instead: GMC cosmetic guidance, the NMC and GDC codes, CAP advertising rules and UK GDPR, plus the PSA-led joint statement on AI principles for registrants.
There is no statutory requirement in England at present, according to the JCCP. A licensing scheme under section 180 of the Health and Care Act 2022 is planned and could add one, but DHSC has not yet published licensing rules or confirmed an insurance condition.
It may, if a qualified practitioner made the treatment decision and used the tool within their competence, subject to the policy terms. Fully autonomous decisions, device defects, advertising complaints and data breaches may be excluded or need separate cover. Tell your insurer which tools you use.
Opened on 21 October 2026 and closing 13 January 2027, it proposes limiting certain high-risk treatments, including some laser procedures, to specified healthcare professionals, treating liquid BBL as surgery, and banning specified procedures for under-18s, enforced by the CQC. Parliamentary process is planned for spring 2027.
Tell us about your practice and the work you do. A broker will review how your current cover treats AI-assisted work, or arrange new cover. No fee for a quote. Or call 0117 325 0027.
Start an indemnity quote Request a callbackApex Insurance Brokers Limited is authorised and regulated by the Financial Conduct Authority. Registered in England and Wales, company number 07014570. This page is general information about how AI is used in the profession and how insurance may respond. It is not legal, regulatory or insurance advice on your circumstances, and it does not guarantee that cover will be available or on what terms.
